Sean Lee
Stock Analyst at HC Wainwright & Co.
(1.62)
# 1447
Out of 5,270 analysts
97
Total ratings
37.29%
Success rate
24.29%
Average return
Main Sectors:
Top Industries:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
Monopar Therapeutics | Maintains: Strong Buy | 22 40 | 31.18 | 28.29% | 9 | Jan 22, 2025 | |
Corvus Pharma | Reiterates: Buy | 11 11 | 3.96 | 177.78% | 2 | Jan 14, 2025 | |
Alphatec Holdings | Reiterates: Buy | 20 20 | 12.28 | 62.87% | 11 | Jan 14, 2025 | |
Verastem | Reiterates: Buy | 7 7 | 5.54 | 26.35% | 12 | Dec 19, 2024 | |
Plus Therapeutics | Reiterates: Buy | 8 | 0.66 | 1112.12% | 10 | Nov 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 8 8 | 4.83 | 55.28% | 4 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 1 1 | 1.02 | -1.96% | 11 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 1 5 | n/a | n/a | 4 | Oct 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 4 1 | n/a | n/a | 14 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 20 20 | 0.81 | 2369.14% | 4 | Jul 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 12 6 | 2.35 | 155.32% | 7 | May 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 5 | n/a | n/a | 7 | Nov 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 30 | 0.95 | 3057.89% | 1 | Dec 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 1 | Mar 19, 2021 |